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06iecGves. Our aim was to determine the applicability, safety 
and &ognostir value of adenosine and dobutr&ne stress echo- 
cardiography in patients 270 years old. 
lluekgmd These tests are sometimes mandatory because of 
diicultles and inaccnracies in interpreting traditional electrocar- 
dllpltic stress tests. Fnrthermore, if tbese tests could be used 
to avoid coronary atteriography and cardiac catheterization, they 
would become essential in tbe care of the elderly, whose numbers 
are iacreasing. 
M&to&. We performed coronary arteriography and dobut- 
amine and adeuosine- stress eclmcardiiphic tests in 120 pa- 
tients (72 men) 270 years old who entered the hospital because of 
chest pain and had knowu or suspected corcuary artery disease. 
The stress tests were performed on separate days, witbin 2 weeks 
of eoronaty arteriograpby. Both the arteriograms and the echo- 
cardiograms were analyzed by two experts wbo bad uo knowledge 
of the patients’ otber data or the other interpreter’s report. Tests 
wem judged to have positive or negative results, and tk patients 
were followed up for the development of cardiac events. Univariate 
The mean life expectancy in the Llnited States has been 
prolonged from 45 to nearly 75 ycarr (1). Consequently, 
increasing numbers of elderly peopk: enter the hospital for 
assessment of chest pain. In these patients, coronary artery 
disease is highly prevalent (2-6) and is the leading cause of 
morbidity and mortality. Furthermore, the use of more aggres- 
sive diagnostic and therapeutic strategies in these patients has 
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and multivariate analyses and other statistical modalities were 
applied for comparisons. 
Results Docnmented coronary artery dfsease was found in 89 
patients. During the 14 f 7 montbs of follow-up, cardiac events 
developed in 50 patients, includii 3 (7.9%) of 38 patients with 
negative dobutamine and l2 (20.7%) of 58 patients with negative 
adenosine test results. Demonstration of any abnormality on 
stress echocardiography was an independent thetor for cardiac 
events, both for dobutamioe (relative risk 7.3) and for adenosine 
(relative risk 3.0). Both cessation of dobotamine or adenosine 
tests and diagnosis of disease in two or more coronary vessels were 
also independent predictors. ST segment depression ?l mm was 
related to future events only with the dobutamiue test. 
Cmfclu5ions. These echocardiograpbii stress tests proved safe 
and well tolerated. They successfblly stratified this cohort of 
elderly patients with coronary artery disease to low or high risk 
subgro-~ps for subsequent cardiic events. 
(J Am con cardi 19%;28:529) 
improved the quality of life and decreased cardiac morbidity 
and mortality (7-9). However, clinical assessment of these 
patients with conventional stress tests is inadequate because of 
their limited capacity to perform or complete these tests 
(IO,1 1). Dipyridamole, adenosine and dobutamine strcrs echo- 
cardiography have been previously used as alternatives to 
exercise testing for detecting coronaty artery disease (12-15). 
The combination of clinical findings and echocardiographic 
test results could help to stratify these patients into low and 
high risk subgroups (16,17). The aim of thii work was to 
investigate the safety and applicability of dobutamine and 
adenosine stress echocardiography and to compare their prog- 
nostic value in the elderly. We anticipated that some guidelines 
for the use of these tests in the clinical management of elderly 
patients with coronary artery disease could be established. 
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Methods 
Study group. One hundred twenty consecutive patients 
~70 years of age with suspected or known coronary anery 
disease. undement dobutamine and adenosine stress echocar- 
diography on different days and in random sequence. The 
patients were included in the study bL‘zau.se they reported 
typical or atypical chest pain and also showed a compromised 
ejection fraction ~30%. The presence and degree of heart 
failure or arrhythmias were not classified. All patients under- 
went coronary arteriography within 2 weeks of dobutamine 
and adenosine stress echocardiography. We excluded 22 pa- 
tients: 4 with heart failure (ejection fraction <30%), 3 with 
valvular heart disease, 2 with ventricular arrhythmias, 2 with 
left bundle branch block, 6 with a recent history of asthma or 
severe chronic obstructive pulmonary disease and 5 with 
unstable angina. All patients had sinus rhythm. None was 
receiving atropine. Thirty patients were capable of completing 
a stress electrocardiogram (ECG); the results were positive in 
16, negative in 10 and nondiagnostic in 4. Thus, in this 
subgroup of the study patients, the ECG stress test showed a 
sensitivity of 86.7%, a specificity of 72.7% and a relative 
predictive value of 81.3%. The study protocol was approved by 
the Ethics Committee of the hospital. All patients signed an 
informed consent form to enter the study. 
Cardiac catheterization. Coronary arteriograms (Judkins 
or Sones technique) were obtained by using multiple views and 
were recorded on 35mm tine film. Coronary stenoses were 
evaluated visually by two experienced angiographers unaware 
of the other data of each patient. Significant coronary artery 
disease was diagnosed when at least one ~50% diameter 
steno& in a major epicardial artery was observed. 
Dobutamine stress. After routine preparation for stress 
testing, a rest ECG and a two-dimensional echocardiogram 
were obtained. Dobutamine was administered intravenously 
with a pump, starting at a dose of 5 @ . kg-’ * min-’ and then 
increasing in increments of 5 pg * kg-’ every 3 min, up to the 
maximal dose of 40 pg * kg-’ * min-‘. An ECG was continu- 
ously monitored. Before the test, at the end of each stage and 
up to 10 min after the end of the infusion, clinical signs, blood 
pressure, 1Zlead ECG and two-dimensional echocardio- 
graphic images were recorded. End points of the test were 
either the achievement of the peak dose administration, or the 
development oE severe &hernia or extensive wall motion 
abnormality (in > 10 of the 16 segments), severe hypertension 
(systolic arterial pressure >230 mm Hg), or hypotension 
(decrease of systolic arterial pressure >20 mm Hg from 
baseline value or an absolute value 590 mm Hg), ventricular 
tachycardia or, complex ventricular extrasystoles and ST seg- 
ment elevation or depression 21 mm. 
Adenosine s-s. Adenosine was infused intravenously at 
a dose of 140 pg * kg-’ * min-’ for 6 min under ECG 
monitoring. Before the test, at the end of each minute and up 
to 2 min after the end of the infusion, clinical signs, 12-lead 
ECG, blood pressure and two-dimensional echocardiographi 
results were recorded. AU patients were advised to avoid 
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consuming coffee, tea or caffeine-containing food or beverages 
for the preceding 12 h. End points equivalent to those used 
with the dobutamine stress echocardiographic test were used, 
but with this protocol, severe side effects leading to termina- 
tion of the test at a submaximal dose included development of 
sinoatrial or, third-degree atrioventricular (AV) block and 
other symptoms, such as severe dyspnea or flushing (which 
rarely occurred with the dobutamine infusion). 
Echocardiiphic studies. Two-dimensional echocardi- 
ography at standard projections (parastemal long- and short- 
axis and apical four- and two-chamber views) were recorded on 
videotape at baseline and during the tests (at the end of each 
stage for the dobutamine test, continuously during the adeno- 
sine test and up to 10 and 2 min during the recovery phase, 
respectively). The echocardiographic images were assessed by 
two experienced observers working separately, without knowl- 
edge of the patients’ clinical or angiographic data or the results 
of the echocardiographic stress test assessed by their counter- 
part. 
For the purpose of analysis, a 16-segment model of the left 
ventricular wall was used (18). Both systolic wall thickening 
and inward motion were evaluated and, according to a gener- 
ally accepted qualitative analysii (19). wall motion was graded 
as 1 (normal), 2 (hypokinetic), 3 (akinetic) or 4 (dyskinetic). 
An ixhemic response was defined by echocardiography as the 
development or worsening of a wail motion abnormal@ 
compared with baseline. On thii b&s, a wall motion abnor- 
mality already present in basal conditions was not considered a 
positive result test. Segments that were hypokinetic at baseline 
and became akinetic on testing were considered positive for 
ischemia. However, segments that were akinetic at baseline 
and became dyskinetic on testing were not considered ischemic 
(20) unless a new or worsening wall motion abnormality also 
developed in two or more adjacent segments. 
Follow-up data were obtained through a telephone inter- 
view, a medii clinii visit or by contacting the referring 
physician. Events included cardiac deaths, nonfatal myocardird 
infarction (hard events), unstable angina necessitating hospital 
admission, coronary bypass surgery or angioplaaty. For survival 
analysis, only one event was considered in each patient; 
therefore, any subsequent event was not considered. 
Statistical analysis. Multivariate stepwise regression anal- 
ysis was performed to detect independent predictors of cardiac 
events. A log-linear model was used to treat the dependent 
(event) and independent variables measured on a nominal 
scale. Those independent variables traditionally considered to 
be related to the evolution of the coronary artery disease were 
included in the analysii. These were gender, history of hyper- 
tension, smoking, hypercColsrterolemin diabetes meltitus, typ 
ical angina, myocardial infarction and dyspnea, Q wave (rest 
ECG), dyskinesia (rest echocardiogram), disease of two or 
more vessels (angiogram), ST depression 21 mm, cessation Of 
the dobutamine or adenosine stress test, positive test results 
and worsening of wall motion. 
A step by step examination of combinations of variables w& 
performed and tbe results were compared among these com- 
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T&e 1. Clinical Characteristics and investigative Variables of the 
120 Study Patients Stratified by Presence or Absence of 
Cardiac Events 
- Cardiac NoCardiac 
Events Events P 
(n = 50) (It = 70) Value 
km (yr) age 15.7 2 3.3 14.9 + 2.6 O.lR.2 
Mea 35 (70%) 37 (52.8%) 0.056 
Asymptomatic 17 (34%) 31(44.3%) 0.079 
Atypical chest pain 5 (10%) 15 (21.4?) 0.052 
Typical angina 28 (56%) 24 (.34.3%) co.05 
Previous MI 29 (58%) 19(27.1%) co.01 
Smoking history 23 (46%) 25 (35.7%) 0.079 
Hypertension 34 (68%) 44 (62.8%) 0.131 
Hypexholesterolemia 33 (66%) 46 (65.7%) 0.155 
Diaberes mellitus 15 (30%) 13 (18.6%) 0.0% 
Smoking and hypertension 19 (38%) 13 (18.6%) co.05 
Beta-blocker therapy 26 (52%) 29 (31.4%) 0.078 
Calcium antagonist therapy 33 (lx%) 34 (48.6%) 0.054 
Nitrate therapy 47 (944) 50 (71.4%) <O.Ol 
Digitalis therapy 9(18%) 14 (20%) O.lRO 
Baseline ejection fraction (%)’ 48.9 ? 10.7 50.85 + 10.6 0.328 
WMA at rest* 41(82$1) 39 (55.7%) co.01 
2- or 3-wssel d&set 43 (86%) 27 (38.6%) <O.Ol 
*Assessed by two-dimensional echocardiography. tA?.sessed by coronary 
arteriography. Data presented are mean value 2 SD or number (%) of patients. 
Ml = myocatdial infarction; WMA = wall motion ahnormalities. 
binations step by step until the procedure reached a maximal p 
value for these variables. At each step, after the addition of a 
new variable, the resulting p value was checked to make sure 
that the log-linear model was improving. Variables producing 
a smaller p value were excluded from the next step. Care was 
taken so that the patient’s condition was best represented with 
the independent variables in use. Relative risk ratios were 
calculated for those variables, found to be statistically signili- 
cant in the multivariate analysis. Actuarial event-free rates 
were analyzed by using survival curves. Data were expressed as 
mean value 2 SD. Where appropriate, 95% confidence inter- 
vals (CI) are given. The calculation of sensitivity, specificity 
and accuracy relied on standard dcbnitions. Univariate analy- 
sis was performed by using the Student t test for interya! data 
and chi-square test for categoric data. A p value ~0.05 was 
considered statistically significant. 
Results 
Foltow-op data. The 120 patients had an overall total of 50 
(42%) cardiac events during the 14 -C 7 month follow-up 
period: 9 cardiac deaths, 4 nonfatal myocardial infarctions, 14 
episodes of unstable angina, 19 coronary bypass grafting 
procedures and 4 coronary angioplasty procedures. As a rule, 
revascularization was undertaken for persistent or worsening 
symptoms despite medical treatment, taking also into consid- 
eration the echocardiographic findings. In only two patients 
the decision for revascularization was also based on the 
coronary anatomy. The patients’ characteristics are presented 
Table 2. Dobutamine and Adenosine Echocardiographic Findings in 
the 120 Study Patients 
Cardiac 
Events 
(0 = 50) 
No Cardiac 
Events P 
(n = 70) Value 
Dobutamine stress test 
Positive result 
Angina 
ST depression 21 mm 
Infusion duration (min) 
Discontinuation of the test* 
SBP reduction 220 mm Hg 
Adcnmine stress test 
Positive 
Angina 
ST depression hl mm 
Infusion duration (min) 
Discontinuation of the test* 
47 (94%) 
24 (48%) 
27 (54cr) 
17.5 ? 5.3 
34 (68%) 
5 (10%) 
38 (76%) 
24 (4R%) 
9 (18%) 
5.1 t 1.3 
19 (38%) 
35 (50%) 
10 (14.3%) 
10 (14.3%) 
21.x f 4.5 
15 (21.4%) 
3 (4.3%) 
24 (34.3%) 
19 (27.1%) 
3 (4.3%) 
5.7 2 0.7 
8(11.4%) 
< 0.001 
< 0.001 
< 0.001 
< 0.001 
< 0.001 
0.138 
< O.ooI 
< 0.05 
< 0.05 
i 0.01 
< 0.01 
‘Because of chest pain. ST segment depression rl mm or extensive wall 
motion abnormality. Data presented are mean value 2 SD or number (%) of 
patients. SBP = systolic blood pressure. 
in Table 1. The mean age of the patients was 75.3 ? 3 years; 72 
(60%) of the 120 patients were men. Forty-eight patients 
(40%) had a history of previous myocardial infarction and 
three had undergone previous aortocoronary bypass surgery. 
All the patients are being followed up. The average 
follow-up time is 14 ? 7 months. Of the 42 patients who have 
been followed up for ~14 months, 9 had had normal arterio- 
graphic findings; among the 33 with abnormal findings, events 
developed in 17 during this follow-up period. The 14-month 
cardiac event rate was higher in patients with than in those 
without a prior myocardial infarction (58% vs. 27%, p < 0.01) 
and in patients with typical angina (56% vs. 34%, p < 0.05). 
The combination of hypertension and smoking (38% vs. 19%, 
p < 0.05) and wall motion abnormalities at rest (82% vs. 56%, 
p < 0.01) were also univariate predictors of cardiac events. 
Coronary arteriography demonstrated one-, two- or three- 
vessel disease in 19, 25 and 45 patients, respectively. The 
incidence of all (n = 50) and hard (n = 13) cardiac events WaS 
greater in patients with multivessel disease (43 of 50 vs. 27 of 
70, p < 0.001 for all cardiac events, 12 of 50 vs. 1 of 70, p < 
0.001 for hard events). 
Dobutamiae ecbocardiipby (Table 2). The dobutamine 
infusion was well tolerated without serious complications in 
most patients. In 12 patients infusion was discontinued because 
of adverse effects: hypotension in 8, hypertension (systolic 
arterial pressure ~230 mm Hg) in 2 and paroxysmal atrial 
fibrillation in 2. Paroxysmal atrial fibrillation developed in one 
additional patient just after the end of the test. In all patients, 
blood pressure returned to the baseline value after discontin- 
uation of the dobutamine infusion without additional treat- 
ment. Roth patients who had systolic arterial pressure 
2230 mm Hg during the test gave a history of hypertension. 
TWO of the patients who experienced atrial fibrillation had a 
previous history of intermittent atrial fibrillation. The atria1 
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Figare 1. Survival cutves for all (A) and hard (B) cardiac events during 
a 1Cmonth follow-up period, according to the results of dobutamine 
stress echocardiography. Ci = confidence interval. 
fibrillation reverted to sinus rhythm either after administration 
of metoprolol or, spontaneously, within 8 h after cessation of 
the test. Other patients experienced minor adverse effects 
(headache or premature atria1 or ventricular contractions) that 
did not prevent completion of the test. 
Both, all (n = 50) and hard (n = 13,13 of 13 vs. 69 of 107, 
p < 0.05) cardiac events (Fig. 1, A and B) occurred more often 
in patients with positive dobutamine stress test results. One 
hundred forty-three new and 127 worsening wall motion 
abnormalities were recorded during the test in 82 patients, and 
transient dyskinesia was recorded in 30 (Table 3). ST segment 
depression 21 mm (Fig. 2) and chest pain after dobutamine 
infusion occurred in 37 (31%) and 34 (28%) patients, respec- 
tively, and were related to cardiac events. Furthermore, the 
duration of the dobutamine infusion was significantly less in 
patients with cardiac events. Discontinuation of the test was 
also related to adverse outcome. 
The sensitivity, specificity and accuracy of dobutamine 
echocardiography are shown in Table 4. The overall sensitivity 
of the dobutamine test for the patients who received or did not 
receive beta-adrenergic blocking agents was similar (86% and 
87%, respectively). 
Adenosine edwardiogmpby (Table 2). The only serious 
adverse effect noted during adenogme infusion was AV block. 
Transient AV block developed in seven patients, including 
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Table 3. Recorded New or Worsening (or both) Wall Motion 
Abnormalities and Transient Dyskinesia During Stress Tests in the 
120 Study Patients 
Cardiac 
Events 
(n = 50) 
NO 
Cardiac 
Event.s 
(n = 70) 
Dobutamine strw tesl 
Only new WMA 
Only worsening WMA 
Both new and worsening WMA 
Transient Mkinesia 
Adenosine stress test 
Only new WMA 
Only worsening WMA 
Both new and worsening WMA 
Transient ekinesia 
15(.3x&) 
I? (245,) 
m(m) 
23(46%) 
18 (36%) 
17 (34%) 
3 (6%) 
8(16sC) 
17 (243%) 
lI(15.76) 
7 (10%) 
7 (WC) 
10 (14.3%, 
9(12.EI) 
5 (7.1% ) 
3 (4.3C) 
0.129 
0.097 
< 0.001 
< 0.01 
c 0.05 
c 0.05 
0.282 
0.052 
Data preanred are numkr (V) of parients. WMA = wall motion abnor- 
malities. 
three patients with first-degree block, two with Wenckebach 
block and two with Mobitz type II seconddegree AV block. 
None of the patients experienced symptoms, and the AV block 
was transient and self-limited. Other patients exhibited minor 
adverse effects (dyspnea, flushing, headache, nausea). No 
patient required treatment with aminophylline and in only one 
patient was adenosine infusion terminated before the end of 
the test, because of flushing and headache. All cardiac events 
(Fig. 3), but not the hard events (9 of 13 vs. 53 of 107, p = 
0.098), were encountered significantls more often in patients 
with a positive adenosine test result. Seventy-eight new and 83 
worsening wall motion abnormalities were recorded during the 
test in 62 patients and transient dyskinesia was recorded in 11 
(Table 3). 
Results of both dobutamine and adenosine tests were 
positive in 59 patients and negative in 35. ST segment depres- 
sion ~1 mm after dobutamine and adenosine infusion oc- 
curred in 37 (31%) and 12 (10%) patients, respectively (p < 
Figare 2. Actuarial event-free suwival rate for patients with (n = 37) 
and without (n = 83) electrocardiographic ST segment depression 
21 mm. 1 he rate was signikantiy better for the patients without such 
S? depression. Cl = confidence interval. 
lhlm6nmwnJ 
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TaBk 4. Sensitivity, Specificiry and Accuracy of Dobutaminc and Adenosine Stress Echocardiography in the Detection of Coronary 
Artery Disease 
Senci!ivity 
overall I-VD .?-VD 3.VD Specifiotv ACCUIKV 
lhbutamine 86.54 (778Y) 74”; [ 14, IQ) 88rr (2’25) 9lG (41’45) 84G (26,31) t%cr (103,/1?0) 
Adenosine 66.34 (59:89) 42s; (X/19) 7ff; (W25) 7lCi (3?:45) Yw (ZXi3l) 72.5? (X7/1 XI) 
p value <_ 0,IllN 0.2?7 O.I?J c ll.ln i O.001 c 0.001 
Data in parenthcsew indicate number of palirna. I-VD , ?-VD. .?-VD = one-. two- and three-vessel disease. respectively. 
0.01). In nine patients ST segment depression ~1 mm was 
detected in both tests: all nine patients had coronary artery 
disease on coronary arteriogrdphy. ST segment depression 
21 mm was related both to cardiac events (p < 0.05) and to 
multivessel disease (11 of 70 vs. 1 of SO, p < 0.05). The 
development of chest pain (48% vs. 27%, p <. 0.05) and 
discontinuation of the test (38% vs. 11%. p < O.Oi) were more 
common in patients with cardiac events. The duration of 
adenosine infusion was also significantly less in patients with 
cardiac events. 
The sensitivity, specificity and accuracy of the adenosine 
test are shown in Table 4. The sensitivity and accuracy of this 
test were statistuzally lower than those of the dobutamine test. 
The adenosine test presented the lowest sensitivity in patients 
with one-vessel disease. 
Statistical analysis. Univariate analysis was applied to 
determine significant predictors of cardiac events from the 
outcome of dobutamine and adenosine testing. As shown in 
Table 1, clinical and investigative predictors were prior mvo- 
cardial infarction, typical angina, the combination of smoking 
and hypertension, wall motion abnormalities at rest, and 
presence of multivessel disease on coronary arteriography. The 
univariate predictors of the dobutamine test (Table 2) were R 
positive test result, presence of chest pain, ST depression 
21 mm, discontinuation of the test, presence of dyskinesia at 
least once during the test and presence of both new and 
Figure 3. Actuarial event-free survival rate for patients with positive 
(n = 62) and negative (n = 58) results of adenosine stress echocardi- 
ography. The rate was significantly better for the patients with negative 
echocardiographic findings. Cl = confidence interval. 
3 301 
i 20; pd).col 95%CI 
10 i 
O+-~+.-.+.--..- * -..,.. -._--._ 
0 2 4 6 a 10 12 ,4 
mm mm) 
worsening wall motion abnormalities during the test. The 
predictive variables of the adenosine test (Table 2) were a 
positive test result, presence of chest pain, ST depression 
~1 mm. discontinuation of the test and presence of worsening 
wall motion abnormalities at least once during performance of 
the test. 
These univariate predictors were entered into multivariate 
stepwise analysis to detect independent predictors of cardiac 
events. These were for b,j!h tests: a positive test result (relative 
risk 7.3 for dobutamine and 3.0 for adenosine), presence of 
two- or three-vessel disease (relative risk 4.4) and Jiscontinu- 
ation of the test (relative risk 3.1 for dobutamine and 2.1 for 
adenosine). In addition, ST depression 21 mm was an inde- 
pendent factor for dobutamine stress echocardiography only 
(relative risk 2.63). The best independent predictor was a 
positive dobutamine stress test result; patients with this finding 
were 7.3 times more likely to have a :-rdiac event than were 
patients with normal test findings. 
Discussion 
Elderly people presenting with chest pain constitute a large 
group of hospi!al patients who need careful clinical assess- 
ment. Because many exhibit silent ischemia (21) and are 
unable to perform exercise tests (22), their invest’zation with 
pharmacologic tests is sometimes mandatq. In this study we 
used dobutamine and adenosine stress czhocardiography to 
evaluate 120 consecutive patients ~70 years old with suspected 
or known coronary artery disease. 
Pharmacology of the agents used. Dobutamine is a pre- 
dominantly beta-receptor agonist and induces myocardial isch- 
emia in patients with coronary artery disease by increasing 
myocardial oxygen demand beyond that which can be met by 
the available coronary vasculature (15,23). Adenosine is a 
vasodilator stressor and was chosen for this study instead of 
dipyridamole because of its shorter half-life and more rapid 
action (24). Furthermore, no previous study had investigated 
the prognostic value of adenosine stress echocardiography in 
elderly patients. 
Studies using adenosine (13,25,26) and dobutamine 
(12,27,28) echocardiography have suggested a high sensitivity 
and specificity for the detection of coronary artery disease. The 
prognostic value of dobutamine stress echocardiography 
(l&29-31) also has been investigated in many studies. How- 
ever, these studies have not focused on the prognostic value of 
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these tests in the elderly, exception for the study of Poidermans 
et al. (15), which used the combination of dobutamine and 
atropine. In their ;!cdy both sensitivity and specificity, as well 
as the predictive value of the tests, were proved satisfactory. 
Comparison of the two tests: predictive value. Our obser- 
vations in this cohort of patients indicate that dobutamine and 
adenosine echocardiographic stress tests are capable of iden- 
tifying elderly patients with extensive (two or more vessels) 
coronary artery disease. In addition, the need lo interrupt 
either test predicts the presence of severe coronary artery 
disease. Adenosine stress echocardiography demonstrated its 
lowest sensitivity in the presence of one-vessel disease. It was 
ies sensitive but more specific tha:i dobutamme stre!iq ech+ 
cardiography in detecting coronary stenoses. These results are 
similar to those reported previous!y (25,26) and indicate that 
both tests can detect the presence of coronary artery disease. 
Aitiough adenosine-a vasodiiator substance-would not be 
expected to increase cardiac work and, hence, the oxygen 
demands of the myocardium, the -2te-przssore product in- 
creased significantly in our study patients dutirp G test. Of 
course, dobutamine stress echocardiography proved more sen- 
sitive in detecting milder forms of coronary artery disease. 
Nevertheless, adenosine echocardiography should not be ex- 
cluded from clinical applications, particularly in elderly pa- 
tients, whenever the clinician does not have enough experience 
with, or does not wish to use, dobutamine stress echocardiog- 
raphy. 
(36) to be a significant predictor for cardiac events. By 
multivariate regression analysis of clinical and intravenous 
dobutamine stress echocardiographic data in patients under- 
going major vascular surgery. age >70 years was a significant 
predictor of perioperative events. In the postcperative series of 
Poidermans et al. (29), nearly 60% of the patients having a 
postoperative cardiac complication, were >70 years of age. 
Similar results were reported by Eagle et al. (37). in another 
study (38), patients who had a cardiac event were significantly 
older (67 t IO years) than those who did not (64 -+ 11 years) 
duri,lg a mean follow-up period of 21 months. 
Baudhuin et al. (39) found that dobutamine stress echocar- 
diography was safe in their elderly patients (mean 66 ? 5 rean, 
range 60 to 78) with a sensitivity and specificity simdar to those 
in their young patients (mean 40 C 7 years, ranF 50 to 59). 
The positive and negative predictive value for foreseeing 
cardiac events was, respectively, 57% and 92% for dobuta- 
mine stress echocardiography and 61% and 79% for adenosine 
stress echocardiography. The predictive value of adeno- 
sine stress echocardicTraphy has not been reported, but the 
positive predictive value of dobutamine stress echocardiogra- 
phy in the p:csent study is similar to that previously described 
(l&16) for dobutamine echocardiography. Mazeika et al. (16) 
found a positive predictive value of 68%. In the same study, the 
negative predictive value was 77%, less than that in our series; 
however, Iaika et al. (31) and Poidermans et al. (29) reported, 
respectively, a negative predictive value of dobutamine stress 
echocardiography for perioperative events of 95% and 99%. 
The positive predictive value of positive findings on dobut- 
amine or adenosine stress echocardiography is at least compa- 
rable to that of dipyridamoie thallium scintigraphy (positive 
predictive value 27% to 58%, negative predictive value 82% to 
100%) (32) for subsequent events and to that of adenosine 
thallium-201 single-photon emission computed tomography 
(positive predictive value 43%, negative predictive value 91%) 
(33) for postinfarction events. These results suggest that in 
many hospitals both dobutamine and adenosine stress echo- 
cardiography could be used as alternative tests for predicting 
cardiac events in unclear cases at a rather low cost. The 
dobutamine test was superior to that of adenosine. 
Dobutamine stress echocardiography caused fewer minor 
adverse effects (headache, tremor. flushing, etc.) than did 
adenosine stress echocardiography. but the procedure lasted 
longer (24 vs. 6 min). However, the two tests were equally well 
tolerated. We found, as have others (43; that the development 
of hypotension with dobutamine infusion was not associated 
with an ischemic response. The percent of AV block recorded 
during adenosine infusion, in the elderly was also similar to that 
reported by others (41). In our series, although subjective 
untoward effects were more frequent with adenosine infusion, 
more serious (and “objective”) untoward effects (ECG irreg- 
ularities and arrhythmias) were recorded with dobutamine 
stress echocardiography. These data indicate that these tests 
can be used as screening tests (dobutamine more so than 
adenosine) to help determine which of these elderly patients 
will need more detailed hemodynamic-angiographic investiga- 
tions. 
Numerous studies have used a pharmacologic stress com- 
bined with echocardiography 0: ihaiiium scintigraphy (34-36) 
to elicit myocardial ischemia and thus determine variables 
associated with an adverse outcome. Age has been reported 
Prediie factors and patient classification. The presence 
of any dobutamine echocardiographic abnormality was the 
most powerful independent predictor of future cardiac events. 
Ninety-four percent of such events occurred in patients with a 
positive dobutamine stress test result in contrast to 86% in 
patients with two- or three-vessel disease and 76% in patients 
with a positive adenosine stress test result. Only 3 patients with 
a negative dobutamine stress test result, but I2 with n ,,egative 
adenosine stress test result, had a cardiac event daring the 
follow-up period. Mazeika et al. (16) reported a similarly low 
incidence of cardiac events in patients with negative dobut- 
amine echocardiographic findings. Krivokapich et al. (17) 
reported that rest wail motion abnormalities were predictive of 
ischemic events, but Eicheiberger et al. (30) found the oppo- 
site. Wall motion abnormalities at rest were present in 80 
(67%) of our patien:s (41 with and 39 without cardiac events) 
and constituted a significant predictor only in patients with a 
history of myocardial infarction (26 of 50 vs. I8 of 70, p < 
0.01). In the remaining patients (15 of 50 vs. 21 of 70, p = 
0X9), because rest wall motion abnormalities do not neces- 
sarily reflect &hernia, it is reasonable to assume that their 
presence is not necessarily related to ischemic events. 
The discontinuation of dobutamine or adenosine stress 
echocardiography (because of chest pain, ST depression 
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>l mm or extensive wall motion abnormalities) was predictive 
of a 3.1 and 2.1 times greater risk for cardiac events, respcc- 
tively. The only clinical univariate predictors were a history of 
myocardial infarction and presence of typical angina. Even 
thou+ risk factors such as smoking, hypercholesterolemia, 
hypertension or diabetes mellitus out not predict cardiac 
events, the combination of smoking and hypertension was a 
significant predictive factor. The patients who had a cardiac 
event, even if results of dobutamine or adenosine stress 
echocardiography, or both, were negative, could be identified 
as a higher risk subset by using these clinical predictors. In our 
study, all patients could be classified in an intermediate risk 
group, because they had at least one clinical risk factor: age 
~70 years. The existence of other clinical entities (overt or 
hidden) could possibly classify the elderly in a significantly 
higher risk class and the presence of positive findings on 
dobutamine or adenosine stress echocardiography at :!x great- 
est risk subset. Furthermore, as a rule, revascularization was 
undertaken for persistent or worsening symptoms despite 
medical treatment. 
Limitatioas of the study and clinical impliitirns. One 
limitation of the present study, as of other similar studies, is the 
subjective, nonquantitative interlxetation of echocardio- 
graphic images (16). However, the echocardiograms were 
always assessed by two investigators who had no knowledge of 
the clinical and angiographic data. 
Our study demonstrates that dobdtamine and adenosine 
stress echocardiography are safe and sensitive for diagnosing 
and stratifying elderly persons with suspected or known coro- 
nary artery disease. These persons already have an increased 
risk for cardiac events, even in the absence of prior myocardial 
infarction or typ:cal angina. Their prognosis can be defined 
further with dobutamine or adenosine stress echocardiogra- 
phy. Abnormal findings on dobutamine stress echocardiogra- 
phy (relative risk 7.3) or adenosine stress echocardiography 
(relative risk 3.0) is an independent predictive factor for 
cardiac events and can identify those patients who are at 
greatest risk for adverse outcome. It is important for the 
diicd cardiologist to be able to classify elderly patients in risk 
level subgroups and to assess their further treatment with the 
use of a simple, safe, nonexpensive, noninvasive test. 
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